MedTrace Logo

Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women

NCT01805674 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2014-11-05

No results posted yet for this study

Summary

In menopause, the vasomotor symptomatology, accompanied or less by affective and behavioural symptoms, globally worsens the quality of daily life.

The improvement of the quality could be reached with adequate food supplements, named phytoestrogens, in particular Soy Isoflavones (SI), which are natural substances with estrogen-like and estrogen-antagonistic activity, which are active in the control of menopausal vasomotor symptoms. Besides, combined with magnolia extract it could improve the psychological symptomatology also improving the quality of life.

Conditions

Interventions

DIETARY_SUPPLEMENT

isoflavones combined with magnolia

1 tablet/day duration: 12 weeks

Sponsors & Collaborators

  • Rottapharm Spain

    lead INDUSTRY

Principal Investigators

  • Anna Anguera, MD, PhD · Rottapharm S.L.

  • Rafael Sánchez-Borrego, MD · Centro Médico Teknon

Eligibility

Min Age
45 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-07-31
Completion
2013-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01805674 on ClinicalTrials.gov